Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Blog | Veristat Insightful Perspectives

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Posts about

Regulatory Submissions (12)

Regulatory Guidance Monthly Review - August 2020

August 2020 

Each month, Veristat's regulatory team tracks and shares a selection of new...

Regulatory Guidance Monthly Review - July 2020

July 2020 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...

Regulatory Guidance Monthly Review - June 2020

June 2020 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...

Regulatory Guidance Monthly Review - May 2020

MAY 2020 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...

Regulatory Guidance Monthly Review - April 2020

April 2020 

Each month, Veristat's regulatory team tracks and shares a selection of new...

Regulatory Guidance Monthly Review - March 2020

March 2020 

Each month, Veristat's regulatory team tracks and shares a selection of new...

MRHA Guidance for Clinical Trials During COVID-19 Outbreak

MHRA Guidance On Clinical Trial Conduct During COVID-19 Pandemic 

Regulatory Insights on COVID-19 Updates From FDA | 31 March 2020

FDA UPDATES -  For Sponsors with Products Intended to Treat Indications Other than COVID-19

In...

Covid-19 Update from FDA | Conduct of Clinical Trials During Covid-19 Outbreak

FDA Guidance On Clinical Trial Conduct During COVID-19 Pandemic -  18 March 2020 

Regulatory Guidance Monthly Review - February 2020

February 2020 

Each month, Veristat's regulatory team tracks and shares a selection of new...